Concepedia

Michael Borofsky

MB

Statistics

Publications

8

Citations

1.2K

H-Index

8

Active since

1989

Affiliations

Reading Hospital(Current)

University of California, San Francisco

Roche (United Kingdom)

Western University

San Francisco VA Medical Center

Michael Borofsky is an author at Reading Hospital specializing in medicine, pharmacotherapy, and rheumatology.

Publications per year

1989–2020

8

Publications

8

Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trial

Dinesh Khanna, Celia J. F. Lin, Daniel E. Furst et al. · The Lancet Respiratory Medicine · 2020 · 652 citations · Full text

, , +4

Cinacalcet Treatment of Primary Hyperparathyroidism: Biochemical and Bone Densitometric Outcomes in a Five-Year Study

Munro Peacock, Michael A. Bolognese, Michael Borofsky et al. · The Journal of Clinical Endocrinology & Metabolism · 2009 · 214 citations

, , +17

Subcutaneous Tocilizumab Versus Placebo in Combination With Disease‐Modifying Antirheumatic Drugs in Patients With Rheumatoid Arthritis

Alan Kivitz, Ewa Olech, Michael Borofsky et al. · Arthritis Care & Research · 2014 · 145 citations · Full text

, , +15

Cinacalcet HCl Reduces Hypercalcemia in Primary Hyperparathyroidism across a Wide Spectrum of Disease Severity

Munro Peacock, John P. Bilezikian, Michael A. Bolognese et al. · The Journal of Clinical Endocrinology & Metabolism · 2010 · 118 citations · Full text

, , +17

Antiphospholipid antibody syndrome with right atrial thrombosis mimicking an atrial myxoma

Lawrence J. Leventhal, Michael Borofsky, Philip Bergey et al. · The American Journal of Medicine · 1989 · 53 citations

, , +13

1–5 of 8